XNAS · Healthcare · Health Information Services
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | Q3 2025 | -1.35 | -107.25 | -7844.44% | $3,618 | ❌ Miss | — | — | — |
| 2025-08-13 | Q2 2025 | -0.09 | -0.22 | -144.44% | $2,682 | ❌ Miss | -4.59% | +3.45% | +9.20% |
| 2025-04-01 |
| Q4 2024 |
| — |
| -0.25 |
| — |
| $611,585 |
| — |
| -5.41% |
| -33.78% |
| -20.95% |
| 2024-08-13 | Q2 2024 | — | -0.68 | — | $278,722 | — | -12.38% | -7.66% | -11.25% |
| 2024-05-14 | Q1 2024 | — | -1.04 | — | $419,646 | — | +0.00% | -5.75% | -27.59% |
| 2024-03-28 | Q4 2023 | — | -0.85 | — | $335,032 | — | — | — | — |
| 2023-11-13 | Q3 2023 | — | -0.78 | — | $715,056 | — | -2.82% | -4.70% | -9.09% |
| 2023-08-10 | Q2 2023 | — | -0.98 | — | $490,110 | — | +1.89% | +1.68% | -22.22% |
Showing last 8 quarters.